DropGenie

DropGenie builds patented chip-based lab automation technology that miniaturizes and parallelizes cell engineering reactions using electrostatic forces — no pumps, no oils. The platform achieves 100x miniaturization, 40x cost reduction, and 100x speed improvement versus conventional methods. It delivers any editing reagent (mRNA, DNA, proteins) into any cell type at nanoliter volumes, enabling arrayed CRISPR screening in precious primary immune cells, optimization of CAR-T and TCR therapies, and large-scale functional validation of AI-predicted drug targets. DropGenie integrates with standard SBS-format automation systems and is compatible with liquid handlers from partners including Sartorius and Beckman Coulter. The company is headquartered in Cambridge, MA with operations in Montreal, QC.